NEW YORK (Reuters Health) – While magnetic resonance imaging is contraindicated for patients with most implanted cardiac devices because of safety concerns, MRI can in fact be performed…
NEW YORK (Reuters Health) – The third edition of the Bayley Scales of Infant and Toddler Development (Bayley-III) overestimates neurodevelopment after early complex cardiac surgery, researchers from Canada…
NEW YORK (Reuters Health) – Direct stent implantation without balloon dilatation can be safely performed in some patients undergoing percutaneous coronary intervention for ST-segment elevated MI (STEMI), and…
NEW YORK (Reuters Health) – Pretreatment with a 600-mg versus a standard 300-mg loading dose of clopidogrel in the setting of urgent percutaneous coronary intervention for ST-segment elevated…
NEW YORK (Reuters Health) – Results of a meta-analysis of randomized trials indicate that percutaneous coronary intervention for left main coronary artery (LMCA) disease is associated with less…
NEW YORK (Reuters Health) – Most patients with allergic reactions to clopidogrel do not need to stop the drug or switch to another antiplatelet drug but rather can…
NEW YORK (Reuters Health) – A simple ultrasound examination of the femoral artery puncture site before elective percutaneous coronary intervention decreases the rate of subsequent vascular complications, a…
NEW YORK (Reuters Health) – Continuing bivalirudin for 4 hours after primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) facilitates early microvascular reperfusion without an…
NEW YORK (Reuters Health) – A Danish study indicates that among patients undergoing percutaneous coronary intervention, the use of zotarolimus-eluting stents (ZESs) rather than sirolimus-eluting stents (SESs) is…
NEW YORK (Reuters Health) – Administering acetylcysteine to patients before and after they undergo coronary or peripheral angiography does not reduce the occurrence of contrast-induced nephropathy, according to…